Dogwood Therapeutics (DWTX) Other Working Capital Changes (2020 - 2026)

Dogwood Therapeutics has reported Other Working Capital Changes for 7 years, with the latest figure at -$360317.0 in Q2 2026.

• On a quarterly basis, Other Working Capital Changes fell 10.96% year-over-year to -$360317.0 in Q2 2026; TTM through Jun 2026 was -$43988.0, a 113.13% decrease from a year earlier, with the FY2025 full-year figure at $208687.0, down 58.16% from the prior year.
• Other Working Capital Changes was -$360317.0 for Q2 2026 at Dogwood Therapeutics, down from -$288886.0 in the prior quarter.
• The five-year high for Other Working Capital Changes was $1.1 million in Q4 2024, with the low at -$570812.0 in Q1 2022.
• Average Other Working Capital Changes over 5 years is -$47878.1, with a median of -$154946.0 recorded in 2023.
• The sharpest annual moves came in 2024 and 2025: Other Working Capital Changes surged 186.17% in 2024, then tumbled 2001.49% in 2025.
• Over 5 years, Other Working Capital Changes stood at $269184.0 in 2022, then jumped by 43.29% to $385708.0 in 2023, then jumped by 186.17% to $1.1 million in 2024, then sank by 65.79% to $377560.0 in 2025, then tumbled by 195.43% to -$360317.0 in 2026.
• The last three Other Working Capital Changes figures came in at -$360317.0 (Q2 2026), -$288886.0 (Q1 2026), and $377560.0 (Q4 2025), per Business Quant data.